Compare the different types of disease modifying drugs (DMDs) that are available to treat relapsing MS.
It is only with the help of our donors, supporters and volunteers that we can continue training MS specialists and providing trusted information to the 100,000 people living with MS across the UK.
This is not a type of MS, but refers to the level of difficulties you face. Here we look at the impact on your daily life, and what can be done to improve things for you.
Find out what help and sources of support are there for family members or friends caring for someone with MS.
Find out about the different signs and symptoms MS presents and which of them are the most common.
We look at the early signs of MS and answer your most common questions and worries about the condition.
The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS.